Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.

Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement

Abstract

Incretin-based therapies, including GLP-1 receptor agonists and dual GLP-1-GIP receptor agonists, have transformed obesity management, producing substantial weight loss and cardiometabolic benefits, with potential improvements in obesity-related complications, physical function, quality of life, and psychological wellbeing for many individuals. However, reduced appetite, rapid weight loss, gastrointestinal adverse effects, and changes in eating behaviour might create nutritional, functional, or psychological risks in some individuals. This EASO-EFAD-ECPO Consensus Statement outlines pragmatic nutritional, functional, and psychological considerations during incretin-based therapy treatment. We synthesise evidence on medical nutrition therapy, including protein targets during weight loss, dietary quality, and mitigation of gastrointestinal adverse events. We discuss pragmatic approaches that could help support preservation of fat-free mass and physical function during weight loss, including adequate protein intake and progressive resistance exercise. We emphasise the psychological and identity-related challenges during incretin-based therapy, including shifts in food reward, coping, and social connection, and recommend psychological screening, with integrated support where needed. We propose pragmatic monitoring during weight loss, including diet quality, micronutrient risk, and functional measures, with body-composition assessment where indicated. We suggest approaches to addr…

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(26)00122-1

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 187 references

Research works printed but not linked: 4

  1. 2015, Scientific opinion on the essential composition of total diet replacements for weight control, EFSA J, 13
  2. 2016, Scientific opinion on dietary reference values for carbohydrates and dietary fibre, EFSA J, 8
  3. 2016, Scientific opinion on dietary reference values for water, EFSA J, 8
  4. Neeland, 2024, Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies, Diabetes Obes Metab, 26, 16, 10.1111/dom.15728 · DOI · Paper page

Cited by

See all 8

Metadata

Authors
Dobbie, L. J., Tolvanen, L., Alves, D., Baker, J. L., Bez, N. S., Birney, S., Bogl, L. H., Brown, A., Bullo, M., Clare, K., Duncan, E. L., Govers, E., Mooney, V., Mulrooney, H., Mercado, D. O., O’Malley, G., Oppert, J.-M., Pillinger, T., Remijnse, W., Shuttlewood, E., Wakolbinger, M., Woodward, E., Yumuk, V. D., Hassapidou, M., Ciudin, A., & McGowan, B.
Affiliations
  • King's College London (GB)
  • Mayo Clinic (US)
  • Guy's and St Thomas' NHS Foundation Trust (GB)
  • Bispebjerg Hospital (DK)
  • Bern University of Applied Sciences (CH)
  • University College Hospital (GB)
  • London Metropolitan University (GB)
  • Ospedale Koelliker (IT)
  • Inserm (FR)
  • University Hospitals Coventry and Warwickshire NHS Trust (GB)
  • European Association for the Study of Obesity (GB)
  • Istanbul University-Cerrahpaşa (TR)
  • International Hellenic University (GR)
  • Universitat Autònoma de Barcelona (ES)
Corresponding author
Dobbie, Laurence J
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2026-09
Volume
14
Issue
9
Pages
754-777
ISSN
2213-8587 (ISSN-L)
OpenAlex
W7167682649
Cited by
8
References
187
Citations by year
2026: 8
FWCI
33.67
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • UKRI Medical Research Council
  • National Institute for Health Research
  • Rosetrees Trust
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Keywords
incretin-based therapy, GLP-1 receptor agonists, GIP/GLP-1 receptor agonist, obesity treatment, weight loss, medical nutrition therapy, protein intake, physical function, gastrointestinal adverse effects, eating behaviour, food reward, psychological well-being, body image, body composition, shared decision-making, medication adherence, access to treatment, quality of life
MeSH terms
Adult, Diabetes Mellitus, Type 2, Humans, Obesity, Quality of Life, Weight Loss, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement. https://app.cochat.ai/papers/10.1016/s2213-8587(26)00122-1
The paper
Dobbie, L. J., Tolvanen, L., Alves, D., Baker, J. L., Bez, N. S., Birney, S., Bogl, L. H., Brown, A., Bullo, M., Clare, K., Duncan, E. L., Govers, E., Mooney, V., Mulrooney, H., Mercado, D. O., O’Malley, G., Oppert, J.-M., Pillinger, T., Remijnse, W., . . . McGowan, B. (2026). Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(26)00122-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.